Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021992
Company: PF PRISM CV
Company: PF PRISM CV
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| PRISTIQ | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | Yes | No |
| PRISTIQ | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | Yes | Yes |
| PRISTIQ | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | Yes | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 02/29/2008 | ORIG-1 | Approval | Type 1 - New Molecular Entity | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021992lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021992s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021992s000TOC.cfm |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 08/18/2023 | SUPPL-51 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021992s051lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/021992Orig1s051ltr.pdf | |
| 09/20/2021 | SUPPL-48 | Labeling-Medication Guide, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s048lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/021992Orig1s048ltr.pdf | |
| 11/10/2021 | SUPPL-47 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s047lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/021992Orig1s047ltr.pdf | |
| 12/19/2017 | SUPPL-46 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021992s046lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021992Orig1s046ltr.pdf | |
| 01/04/2017 | SUPPL-44 | Labeling-Package Insert |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021992s044lbl.pdf | |
| 08/26/2016 | SUPPL-43 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021992s043lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021992Orig1s043ltr.pdf | |
| 02/06/2018 | SUPPL-42 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021992s042lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021992Orig1s042ltr.pdf | |
| 03/16/2016 | SUPPL-41 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 07/17/2014 | SUPPL-40 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021992s040lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021992Orig1s040ltr.pdf | |
| 08/20/2014 | SUPPL-39 |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021992Orig1s039lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021992Orig1s039ltr.pdf | ||
| 12/23/2013 | SUPPL-37 | Labeling-Package Insert, Labeling-Patient Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021992s037lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021992Orig1s037ltr.pdf | |
| 02/14/2013 | SUPPL-36 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021992s033s036lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021992Orig1s033,s036ltr.pdf | |
| 04/19/2013 | SUPPL-35 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 12/07/2012 | SUPPL-34 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021992s034lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021992Orig1s034ltr.pdf | |
| 02/14/2013 | SUPPL-33 | Efficacy-New Indication |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021992s033s036lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021992Orig1s033,s036ltr.pdf | |
| 12/10/2013 | SUPPL-31 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021992s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021992Orig1s031ltr.pdf | |
| 03/07/2012 | SUPPL-30 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021992s030lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021992s030ltr.pdf | |
| 04/11/2011 | SUPPL-22 | Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021992s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021992s022ltr.pdf | |
| 03/04/2011 | SUPPL-21 | Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021992s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021992s021ltr.pdf | |
| 01/31/2011 | SUPPL-20 | Labeling-Package Insert, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021992s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021992s020ltr.pdf | |
| 12/29/2010 | SUPPL-19 | Labeling, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021992s019ltr.pdf | |
| 09/08/2010 | SUPPL-17 | Labeling, Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021992s017ltr.pdf | |
| 07/09/2010 | SUPPL-15 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021992s015ltr.pdf | |
| 10/18/2010 | SUPPL-13 | Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021992s013ltr.pdf | |
| 02/16/2010 | SUPPL-11 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021992s011ltr.pdf | |
| 11/09/2009 | SUPPL-9 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021992s009ltr.pdf | |
| 11/09/2009 | SUPPL-8 | Labeling-Medication Guide |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021992s008ltr.pdf |
| 08/31/2009 | SUPPL-7 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s001s006s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021992s001,006,007ltr.pdf | |
| 08/31/2009 | SUPPL-6 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s001s006s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021992s001,006,007ltr.pdf | |
| 04/23/2009 | SUPPL-5 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021992s005ltr.pdf | |
| 01/30/2009 | SUPPL-4 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021992s004ltr.pdf | |
| 08/31/2009 | SUPPL-1 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s001s006s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021992s001,006,007ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 08/18/2023 | SUPPL-51 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021992s051lbl.pdf | |
| 11/10/2021 | SUPPL-47 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s047lbl.pdf | |
| 09/20/2021 | SUPPL-48 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s048lbl.pdf | |
| 09/20/2021 | SUPPL-48 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s048lbl.pdf | |
| 02/06/2018 | SUPPL-42 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021992s042lbl.pdf | |
| 12/19/2017 | SUPPL-46 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021992s046lbl.pdf | |
| 01/04/2017 | SUPPL-44 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021992s044lbl.pdf | |
| 08/26/2016 | SUPPL-43 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021992s043lbl.pdf | |
| 08/20/2014 | SUPPL-39 | Type 1 - New Molecular Entity | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021992Orig1s039lbl.pdf | |
| 07/17/2014 | SUPPL-40 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021992s040lbl.pdf | |
| 12/23/2013 | SUPPL-37 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021992s037lbl.pdf | |
| 12/23/2013 | SUPPL-37 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021992s037lbl.pdf | |
| 12/10/2013 | SUPPL-31 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021992s031lbl.pdf | |
| 02/14/2013 | SUPPL-36 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021992s033s036lbl.pdf | |
| 02/14/2013 | SUPPL-33 | Efficacy-New Indication | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021992s033s036lbl.pdf | |
| 12/07/2012 | SUPPL-34 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021992s034lbl.pdf | |
| 03/07/2012 | SUPPL-30 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021992s030lbl.pdf | |
| 04/11/2011 | SUPPL-22 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021992s022lbl.pdf | |
| 03/04/2011 | SUPPL-21 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021992s021lbl.pdf | |
| 01/31/2011 | SUPPL-20 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021992s020lbl.pdf | |
| 01/31/2011 | SUPPL-20 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021992s020lbl.pdf | |
| 12/29/2010 | SUPPL-19 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s019lbl.pdf | |
| 12/29/2010 | SUPPL-19 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s019lbl.pdf | |
| 10/18/2010 | SUPPL-13 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s013lbl.pdf | |
| 09/08/2010 | SUPPL-17 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s017lbl.pdf | |
| 09/08/2010 | SUPPL-17 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s017lbl.pdf | |
| 07/09/2010 | SUPPL-15 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s015lbl.pdf | |
| 02/16/2010 | SUPPL-11 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021992s011lbl.pdf | |
| 11/09/2009 | SUPPL-9 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s009lbl.pdf | |
| 08/31/2009 | SUPPL-7 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s001s006s007lbl.pdf | |
| 08/31/2009 | SUPPL-6 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s001s006s007lbl.pdf | |
| 08/31/2009 | SUPPL-1 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s001s006s007lbl.pdf | |
| 04/23/2009 | SUPPL-5 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s005lbl.pdf | |
| 01/30/2009 | SUPPL-4 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021992s004lbl.pdf | |
| 02/29/2008 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021992lbl.pdf |
PRISTIQ
TABLET, EXTENDED RELEASE;ORAL; EQ 50MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204065 | ACTAVIS LABS FL |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204003 | ALEMBIC |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204082 | HIKMA |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204805 | INTELLIPHARMACEUTICS |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204172 | LUPIN LTD |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204028 | RUBICON |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 210014 | YICHANG HUMANWELL |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204020 | ZYDUS PHARMS |
| PRISTIQ | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | Yes | AB | 021992 | PF PRISM CV |
TABLET, EXTENDED RELEASE;ORAL; EQ 100MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204065 | ACTAVIS LABS FL |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204003 | ALEMBIC |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204083 | HIKMA |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204805 | INTELLIPHARMACEUTICS |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204172 | LUPIN LTD |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204028 | RUBICON |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 210014 | YICHANG HUMANWELL |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204020 | ZYDUS PHARMS |
| PRISTIQ | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | Yes | AB | 021992 | PF PRISM CV |
TABLET, EXTENDED RELEASE;ORAL; EQ 25MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204065 | ACTAVIS LABS FL |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204003 | ALEMBIC |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204082 | HIKMA |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204172 | LUPIN LTD |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204028 | RUBICON |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 210014 | YICHANG HUMANWELL |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204020 | ZYDUS PHARMS |
| PRISTIQ | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | Yes | AB | 021992 | PF PRISM CV |